Goran Eryavec

578 total citations
17 papers, 422 citations indexed

About

Goran Eryavec is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Goran Eryavec has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in Goran Eryavec's work include Dementia and Cognitive Impairment Research (8 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Posttraumatic Stress Disorder Research (3 papers). Goran Eryavec is often cited by papers focused on Dementia and Cognitive Impairment Research (8 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Posttraumatic Stress Disorder Research (3 papers). Goran Eryavec collaborates with scholars based in Canada. Goran Eryavec's co-authors include Nathan Herrmann, Krista L. Lanctôt, Lana S. Rothenburg, Robert van Reekum, Claudio A. Naranjo, David Conn, Tammy Cohen, Diana E. Clarke, Nathan Herrmann and Jaclyn Cappell and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Psychoneuroendocrinology and Alzheimer s & Dementia.

In The Last Decade

Goran Eryavec

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Goran Eryavec Canada 12 237 81 77 76 58 17 422
Fiona Clague United Kingdom 6 279 1.2× 90 1.1× 76 1.0× 74 1.0× 93 1.6× 6 540
Sonia Pawluczyk United States 11 189 0.8× 43 0.5× 70 0.9× 66 0.9× 38 0.7× 12 394
Deena J. Tampi United States 12 330 1.4× 96 1.2× 82 1.1× 88 1.2× 81 1.4× 35 653
Laura Jakimovich United States 7 412 1.7× 112 1.4× 122 1.6× 103 1.4× 57 1.0× 16 554
Dario Mirski United States 16 421 1.8× 74 0.9× 107 1.4× 172 2.3× 54 0.9× 19 628
Shirish Patel United States 7 223 0.9× 61 0.8× 61 0.8× 77 1.0× 30 0.5× 8 415
Chay‐Hoon Tan Singapore 14 270 1.1× 39 0.5× 83 1.1× 55 0.7× 43 0.7× 24 592
Rosemary Erb United States 7 505 2.1× 152 1.9× 108 1.4× 118 1.6× 56 1.0× 7 641
Mala Naik Norway 14 267 1.1× 33 0.4× 122 1.6× 30 0.4× 94 1.6× 32 644
İbrahim Günay United States 13 300 1.3× 82 1.0× 81 1.1× 157 2.1× 27 0.5× 15 533

Countries citing papers authored by Goran Eryavec

Since Specialization
Citations

This map shows the geographic impact of Goran Eryavec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goran Eryavec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goran Eryavec more than expected).

Fields of papers citing papers by Goran Eryavec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goran Eryavec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goran Eryavec. The network helps show where Goran Eryavec may publish in the future.

Co-authorship network of co-authors of Goran Eryavec

This figure shows the co-authorship network connecting the top 25 collaborators of Goran Eryavec. A scholar is included among the top collaborators of Goran Eryavec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goran Eryavec. Goran Eryavec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Herrmann, Nathan, Myuri Ruthirakuhan, Alexander Kiss, et al.. (2015). A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease. Journal of the American Medical Directors Association. 17(2). 142–147. 36 indexed citations
2.
3.
Lanctôt, Krista L., Myuri Ruthirakuhan, Goran Eryavec, et al.. (2015). Cholinesterase Inhibitor Discontinuation in Institutionalized Persons with Moderate to Severe AD: Results of a Double-Blind, Placebo Controlled Trial. American Journal of Geriatric Psychiatry. 23(3). S172–S173. 1 indexed citations
4.
Lanctôt, Krista L., et al.. (2013). Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease. Canadian Geriatrics Journal. 16(4). 180–185. 14 indexed citations
5.
Herrmann, Nathan, Jaclyn Cappell, Goran Eryavec, & Krista L. Lanctôt. (2011). Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimerʼs Disease. CNS Drugs. 25(5). 425–433. 23 indexed citations
6.
Lanctôt, Krista L., Nathan Herrmann, Lana S. Rothenburg, & Goran Eryavec. (2006). Behavioral correlates of GABAergic disruption in Alzheimer's disease. International Psychogeriatrics. 19(1). 151–158. 47 indexed citations
7.
Herrmann, Nathan, Krista L. Lanctôt, Lana S. Rothenburg, & Goran Eryavec. (2006). A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 23(2). 116–119. 77 indexed citations
8.
Herrmann, Nathan, et al.. (2004). Growth hormone response to clonidine predicts aggression in Alzheimer’s disease. Psychoneuroendocrinology. 29(9). 1192–1197. 19 indexed citations
9.
Herrmann, Nathan, et al.. (2004). Noradrenergic Activity is Associated with Response to Pindolol in Aggressive Alzheimer’s Disease Patients. Journal of Psychopharmacology. 18(2). 215–220. 20 indexed citations
10.
Lanctôt, Krista L., Nathan Herrmann, Robert van Reekum, Goran Eryavec, & Claudio A. Naranjo. (2002). Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease. International Journal of Geriatric Psychiatry. 17(6). 531–541. 45 indexed citations
11.
Reekum, Robert van, David Conn, Diana E. Clarke, et al.. (2002). A Randomized, Placebo-Controlled Trial of the Discontinuation of Long-Term Antipsychotics in Dementia. International Psychogeriatrics. 14(2). 197–210. 62 indexed citations
12.
Lanctôt, Krista L., et al.. (1999). Gender variations in effect of sertraline on behavioral disorders (BD) in Alzheimer's disease (AD). Clinical Pharmacology & Therapeutics. 65(2). 190–190. 2 indexed citations
13.
Herrmann, Nathan & Goran Eryavec. (1996). Lifetime Alcohol Abuse in Institutionalized World War II Veterans. American Journal of Geriatric Psychiatry. 4(1). 39–45. 6 indexed citations
14.
Herrmann, Nathan & Goran Eryavec. (1996). Lifetime Alcohol Abuse in Institutionalized World War II Veterans. American Journal of Geriatric Psychiatry. 4(1). 39–45. 3 indexed citations
15.
Herrmann, Nathan & Goran Eryavec. (1994). Posttraumatic Stress Disorder in Institutionalized World War II Veterans. American Journal of Geriatric Psychiatry. 2(4). 324–331. 12 indexed citations
16.
Herrmann, Nathan & Goran Eryavec. (1994). Delayed Onset Post-Traumatic Stress Disorder in World war Ii Veterans. The Canadian Journal of Psychiatry. 39(7). 439–441. 25 indexed citations
17.
Herrmann, Nathan & Goran Eryavec. (1993). Buspirone in the Management of Agitation and Aggression Associated With Dementia. American Journal of Geriatric Psychiatry. 1(3). 249–253. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona Clague Breakdown of academic impact, for papers by Sonia Pawluczyk Breakdown of academic impact, for papers by Deena J. Tampi Breakdown of academic impact, for papers by Laura Jakimovich Breakdown of academic impact, for papers by Dario Mirski Breakdown of academic impact, for papers by Shirish Patel Breakdown of academic impact, for papers by Chay‐Hoon Tan Breakdown of academic impact, for papers by Rosemary Erb Breakdown of academic impact, for papers by Mala Naik Breakdown of academic impact, for papers by İbrahim Günay
Rankless by CCL
2026